We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$219M
AUM Growth
+$15.6M
Cap. Flow
+$1.2M
Cap. Flow %
0.55%
Top 10 Hldgs %
24.85%
Holding
101
New
4
Increased
36
Reduced
31
Closed
–

Top Buys

Rank Stock Value
1
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$452K
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$365K
3
UNH icon
UnitedHealth
UNH
+$213K
4
CLX icon
Clorox
CLX
+$195K
5
QCOM icon
Qualcomm
QCOM
+$195K

Top Sells

Rank Stock Value
1
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
+$167K
2
CL icon
Colgate-Palmolive
CL
+$148K
3
MA icon
Mastercard
MA
+$134K
4
HD icon
Home Depot
HD
+$111K
5
PFE icon
Pfizer
PFE
+$105K

Sector Composition

Rank Sector Weight
1 Technology 14.9%
2 Industrials 13.7%
3 Healthcare 12.56%
4 Financials 10.53%
5 Consumer Staples 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUBB icon
101
Hubbell
HUBB
$25B
$204K 0.09%
+1,530
New +$188K
1 2 3 4
5

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return
GPA
Guidance Point Advisors Wellesley, Massachusetts $422M AUM 16.47% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return

Boston Research & Management's Q3 2018 Portfolio in Review

As of Q3 2018, Boston Research & Management held 101 positions worth $219M, up 7.7% from $203M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 4%. Boston Research & Management opened 4 new positions and made no exits, leaving the 101-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

  • Boston Research & Management's largest Q3 2018 buy was UnitedHealth: 818 shares worth $217K.
  • Boston Research & Management added most to iShares Core MSCI EAFE ETF in Q3 2018, an estimated $452K increase.
  • Boston Research & Management's biggest Q3 2018 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $167K.
  • Boston Research & Management's ten largest holdings make up 25% of its $219M portfolio in Q3 2018.
  • Boston Research & Management opened 4 new positions and closed 0 in Q3 2018.
  • Boston Research & Management's portfolio value rose 7.7% quarter-over-quarter to $219M.

Based on Boston Research & Management's 13F filing for Q3 2018, filed 13 Nov 2018.